Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergio Yactayo

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of the American Geriatrics Society|September 24, 2017
Atypical Clinical Presentations of Acute Phase Chikungunya Virus Infection in Older AdultsLidvine Godaert, Fatiha Najioullah, Seendy Bartholet, et al.
Plos Medicine|May 8, 2014
Yellow Fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological dataTini Garske, Maria D Van Kerkhove, Sergio Yactayo, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|June 21, 2014
Yellow fever risk assessment in the Central African RepublicJ Erin Staples, Mawlouth Diallo, Kristen B Janusz, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|May 26, 2012
Immunogenicity and safety of yellow fever vaccine among 115 HIV-infected patients after a preventive immunisation campaign in MaliMariam Sidibe, Sergio Yactayo, Abdoulaye Kalle, et al.
BMC Public Health|August 16, 2018
Sero-prevalence of yellow fever and related Flavi viruses in Ethiopia: a public health perspectiveMesfin Mengesha Tsegaye, Berhane Beyene, Workenesh Ayele, et al.
The Lancet. Infectious Diseases|August 21, 2017
Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysisFreya M Shearer, Catherine L Moyes, David M Pigott, et al.
The Lancet. Global Health|February 6, 2018
Existing and potential infection risk zones of yellow fever worldwide: a modelling analysisFreya M Shearer, Joshua Longbottom, Annie J Browne, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of the American Geriatrics Society|September 24, 2017
Atypical Clinical Presentations of Acute Phase Chikungunya Virus Infection in Older AdultsLidvine Godaert, Fatiha Najioullah, Seendy Bartholet, et al.
Plos Medicine|May 8, 2014
Yellow Fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological dataTini Garske, Maria D Van Kerkhove, Sergio Yactayo, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|June 21, 2014
Yellow fever risk assessment in the Central African RepublicJ Erin Staples, Mawlouth Diallo, Kristen B Janusz, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|May 26, 2012
Immunogenicity and safety of yellow fever vaccine among 115 HIV-infected patients after a preventive immunisation campaign in MaliMariam Sidibe, Sergio Yactayo, Abdoulaye Kalle, et al.
BMC Public Health|August 16, 2018
Sero-prevalence of yellow fever and related Flavi viruses in Ethiopia: a public health perspectiveMesfin Mengesha Tsegaye, Berhane Beyene, Workenesh Ayele, et al.
The Lancet. Infectious Diseases|August 21, 2017
Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysisFreya M Shearer, Catherine L Moyes, David M Pigott, et al.
The Lancet. Global Health|February 6, 2018
Existing and potential infection risk zones of yellow fever worldwide: a modelling analysisFreya M Shearer, Joshua Longbottom, Annie J Browne, et al.
Pageof 2